Stock Market News1 week Vertex Has $5 Billion-Plus Opportunity In Pain And Kidney Disease Programs, Analyst Upgrades Stock Yahoo Finance
Vertex Has $5 Billion-Plus Opportunity In Pain And Kidney Disease Programs, Analyst Upgrades Stock.
X3 hours Health AI startup Suki deliver patient summary, Q&A features for clinicians with Google Cloud CNBC
X2 days Why Vertex Pharmaceuticals (VRTX) Outpaced the Stock Market Today Zacks
X2 days BMY vs. VRTX: Which Stock Is the Better Value Option? Zacks
X7 days Vertex Pharmaceuticals: Progress Check Suggests Stock Remains A Solid Buy Seeking Alpha
X1 week Vertex Pharmaceuticals (VRTX) Falls More Steeply Than Broader Market: What Investors Need to Know Zacks
X2 weeks Why Is Vertex (VRTX) Down 8.6% Since Last Earnings Report? Zacks
X2 weeks Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know Zacks
X2 weeks Google Cloud launches Veo AI video generator model on Vertex VentureBeat
X2 weeks Vertex (VERX) is an Incredible Growth Stock: 3 Reasons Why Zacks
X3 weeks Vertex (VERX) is a Great Momentum Stock: Should You Buy? Zacks
X3 weeks GILD vs. VRTX: Which Stock Should Value Investors Buy Now? Zacks
X3 weeks Vertex, Inc. (VERX) Hit a 52 Week High, Can the Run Continue? Zacks
X3 weeks Is Vertex Stock Worth Buying Despite Its 105% Year-to-Date Rally? Zacks
X3 weeks Vertex Pharma: Why I Am Buying This Dip Seeking Alpha
X4 weeks MCK Stock Down Despite Latest Partnership to Boost SCD Treatment Zacks
X4 weeks Vertex Pharmaceuticals Incorporated (VRTX) Presents at Stifel 2024 Healthcare Conference (Transcript) Seeking Alpha
X4 weeks Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know Zacks
X1 month Why Vertex (VERX) Might be Well Poised for a Surge Zacks
X1 month 3 Reasons Growth Investors Will Love Vertex (VERX) Zacks
X1 month What Makes Vertex (VERX) a Strong Momentum Stock: Buy Now? Zacks
X1 month GILD or VRTX: Which Is the Better Value Stock Right Now? Zacks
X1 month Vertex: Downgrading To A Hold As Upside Is Limited Seeking Alpha
X1 month Market Update: ENB, MCHP, VRTX, XOM, YUM, GNRC, RITM Yahoo Finance
X1 month Vertex (VRTX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates Zacks
X1 month Vertex Pharmaceuticals: Strong Execution Continued In Q3 But The Valuation Reflects It Seeking Alpha
X1 month VRTX Q3 Earnings & Sales Trump Estimates, ’24 Sales View Raised Zacks
X1 month Vertex Pharmaceuticals Incorporated 2024 Q3 – Results – Earnings Call Presentation Seeking Alpha
X1 month Vertex Pharmaceuticals Incorporated (VRTX) Q3 2024 Earnings Call Transcript Seeking Alpha
X1 month Vertex Flashes A Surprise Buy Point As Non-Opioid Pain Drug Looms Investor's Business Daily
X2 months Vertex Gears Up to Report Q3 Earnings: Is a Beat in the Cards? Zacks
X2 months Vertex Pharmaceuticals (VRTX) Stock Drops Despite Market Gains: Important Facts to Note Zacks
X2 months Vivid Wealth Management LLC Purchases Shares of 4,352 Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) MarketBeat
X2 months Sequoia Financial Advisors LLC Raises Stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) MarketBeat
X2 months BMY or VRTX: Which Is the Better Value Stock Right Now? Zacks
X2 months Why Vertex Pharmaceuticals (VRTX) Dipped More Than Broader Market Today Zacks
X2 months Vertex Pharmaceuticals (NASDAQ:VRTX) Given Buy Rating at HC Wainwright MarketBeat
X2 months Vertex Pharmaceuticals: A Long-Term Growth Monster Seeking Alpha
X2 months 1,479 Shares in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Purchased by Net Worth Advisory Group MarketBeat
XThe Stock Market News
TheStockMarketNews.com is a financial news aggregator for traders and investors that proposes to you the latest breaking news headlines on global financial markets, economy and business. Live trading analysis, opinions and forecasts on current stock market, currencies (Forex), cryptocurrency, commodities futures, ETFs, funds, bonds, rates and more. Disclaimer: by using any material of this website, you acknowledge and agree that TheStockMarketNews.com is not responsible for the content, actions or any legal issues arising from third-party websites; materials of this website are not financial advice or call to actions. Trading and investing in financial instruments involve high risks including the risk of investment loss.